Vanda Pharmaceuticals Inc. (VNDA)

USD 4.55

(-3.81%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 648.44 Million 634.24 Million 593.79 Million 533.45 Million 483.74 Million 332.13 Million
Total Current Assets 432.94 Million 519.29 Million 478.3 Million 409.14 Million 354.13 Million 299.13 Million
Cash And Short Term Investments 388.26 Million 466.85 Million 432.81 Million 367.74 Million 312.12 Million 257.36 Million
Cash and Cash Equivalents 135.82 Million 135.02 Million 52.07 Million 61.03 Million 45.07 Million 61 Million
Short Term Investments 252.44 Million 331.83 Million 380.74 Million 306.7 Million 267.05 Million 196.35 Million
Net Receivables 34.15 Million 33.51 Million 32.46 Million 30.03 Million 26.36 Million 28.78 Million
Inventory 1.35 Million 1.19 Million 1.02 Million 1.28 Million 1.14 Million 994 Thousand
Other Current Assets 9.17 Million 17.72 Million 11.99 Million 10.08 Million 14.5 Million 11.99 Million
Total Non-Current Assets 215.49 Million 114.95 Million 115.49 Million 124.31 Million 129.61 Million 32.99 Million
Net PPE 9.14 Million 10.97 Million 12.38 Million 14.59 Million 15.04 Million 4.41 Million
Good Will And Intangible Assets 121.36 Million 18.56 Million 20.08 Million 21.55 Million 23.03 Million 24.54 Million
Good Will - - - - - -
Intangible Assets 121.36 Million 18.56 Million 20.08 Million 21.55 Million 23.03 Million 24.54 Million
Long-Term Investments 469 Thousand 469 Thousand 519 Thousand 525 Thousand 578 Thousand 600 Thousand
Tax Assets 75 Million 74.03 Million 74.87 Million 81.51 Million 87.68 Million -600 Thousand
Other Non Current Assets 9.51 Million 10.9 Million 7.62 Million 6.11 Million 3.27 Million 4.03 Million
Other Assets - - - - - -
Total Liabilities 103.53 Million 107.04 Million 88.86 Million 80.19 Million 72.8 Million 56.7 Million
Total Current Liabilities 87.69 Million 91.43 Million 74.41 Million 65.93 Million 59.5 Million 53.01 Million
Account Payables 9.55 Million 12.69 Million 925 Thousand 5.81 Million 5.9 Million 5.17 Million
Tax Payables - - - - - -
Short Term Debt 2.39 Million 2.32 Million 2.31 Million 2.11 Million 2.14 Million -
Deferred Revenue - - - -5.81 Million -5.9 Million -
Other Current Liabilities 75.74 Million 76.41 Million 71.18 Million 63.81 Million 57.35 Million 47.84 Million
Total Non Current Liabilities 15.83 Million 15.61 Million 14.44 Million 14.25 Million 13.29 Million 3.69 Million
Long-Term Debt 7 Million 8.81 Million 10.05 Million 11.49 Million 12.45 Million -
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 8.82 Million 6.8 Million 4.39 Million 2.75 Million 843 Thousand 3.59 Million
Other Liabilities 1.00 - - - - -
Total Equity 544.91 Million 527.19 Million 504.92 Million 453.26 Million 410.94 Million 275.42 Million
Stock Holders Equity 544.91 Million 527.19 Million 504.92 Million 453.26 Million 410.94 Million 275.42 Million
Common Stock 58 Thousand 57 Thousand 56 Thousand 55 Thousand 54 Thousand 52 Thousand
Retained Earnings -155.39 Million -157.9 Million -164.17 Million -197.32 Million -220.66 Million -336.21 Million
Accumulated other comprehensive income -29.99 Thousand -1.19 Million -175 Thousand 239 Thousand 249 Thousand 1000.00
Common Stock Equity 544.91 Million 527.19 Million 504.92 Million 453.26 Million 410.94 Million 275.42 Million
Capital Lease Obligation 7 Million 8.81 Million 10.05 Million 13.61 Million 12.45 Million -
Total Investments 252.91 Million 331.83 Million 380.74 Million 306.7 Million 267.05 Million 196.35 Million
Total Debt 9.4 Million 11.14 Million 10.05 Million 13.61 Million 12.45 Million -
Net Debt -126.41 Million -123.88 Million -42.01 Million -47.41 Million -32.61 Million -61 Million

Balance Sheet Charts